Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 16-Jul-2019
No. of pages: 104
Inquire Before Buying

NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.

The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.

In 2018, the global Clinical Oncology Next Generation Sequencing (NGS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.

The key players covered in this study

- Illumina

- Roche

- Agilent Technologies

- Knome

- Genomatix Software

- GATC Biotech

- Oxford Nanopore Technologies

- Macrogen

- Life Technologies

- DNASTAR

- Exosome Diagnostics

- Biomatters

- CLC Bio

- BGI

- Qiagen

- Perkin Elmer

- Pacific Bioscience

- Partek

- GnuBIO

- Foundation Medicine

- Paradigm

- Caris Life Sciences

- Myriad Genetics

Market segment by Type, the product can be split into

- NGS Pre-Sequencing

- Sequencing

- NGS Data Analysis

- Primary, Secondary & Tertiary Data Analysis

Market segment by Application, split into

- Academic & Clinical Research

- Hospitals & Clinics

- Pharma & Biotech Entities

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players.

- To present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Clinical Oncology Next Generation Sequencing (NGS) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2014-2025)
1.4.2 NGS Pre-Sequencing
1.4.3 Sequencing
1.4.4 NGS Data Analysis
1.4.5 Primary, Secondary & Tertiary Data Analysis
1.5 Market by Application
1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2025)
1.5.2 Academic & Clinical Research
1.5.3 Hospitals & Clinics
1.5.4 Pharma & Biotech Entities
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size
2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2014-2025)
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Manufacturers
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.3 Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
3.4 Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019)
4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019)
5 United States
5.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
5.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in United States
5.3 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
5.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
6 Europe
6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
6.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Europe
6.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
6.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
7 China
7.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
7.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in China
7.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
7.4 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
8 Japan
8.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
8.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Japan
8.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
8.4 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
9.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Southeast Asia
9.3 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
9.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
10 India
10.1 India Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
10.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in India
10.3 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
10.4 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
11 Central & South America
11.1 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
11.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Central & South America
11.3 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
11.4 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.1.5 Illumina Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.3.5 Agilent Technologies Recent Development
12.4 Knome
12.4.1 Knome Company Details
12.4.2 Company Description and Business Overview
12.4.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.4.5 Knome Recent Development
12.5 Genomatix Software
12.5.1 Genomatix Software Company Details
12.5.2 Company Description and Business Overview
12.5.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.5.5 Genomatix Software Recent Development
12.6 GATC Biotech
12.6.1 GATC Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.6.5 GATC Biotech Recent Development
12.7 Oxford Nanopore Technologies
12.7.1 Oxford Nanopore Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.7.5 Oxford Nanopore Technologies Recent Development
12.8 Macrogen
12.8.1 Macrogen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.8.5 Macrogen Recent Development
12.9 Life Technologies
12.9.1 Life Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.9.5 Life Technologies Recent Development
12.10 DNASTAR
12.10.1 DNASTAR Company Details
12.10.2 Company Description and Business Overview
12.10.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.10.5 DNASTAR Recent Development
12.11 Exosome Diagnostics
12.12 Biomatters
12.13 CLC Bio
12.14 BGI
12.15 Qiagen
12.16 Perkin Elmer
12.17 Pacific Bioscience
12.18 Partek
12.19 GnuBIO
12.20 Foundation Medicine
12.21 Paradigm
12.22 Caris Life Sciences
12.23 Myriad Genetics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Clinical Oncology Next Generation Sequencing (NGS) Key Market Segments
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Covered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type 2014-2025
Figure NGS Pre-Sequencing Figures
Table Key Players of NGS Pre-Sequencing
Figure Sequencing Figures
Table Key Players of Sequencing
Figure NGS Data Analysis Figures
Table Key Players of NGS Data Analysis
Figure Primary, Secondary & Tertiary Data Analysis Figures
Table Key Players of Primary, Secondary & Tertiary Data Analysis
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic & Clinical Research Case Studies
Figure Hospitals & Clinics Case Studies
Figure Pharma & Biotech Entities Case Studies
Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2025 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2025 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2019 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2019
Table Market Top Trends
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers in 2018
Table Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
Table Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2014-2019)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Application (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application in 2018
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-20189) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Table Illumina Company Details
Table Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) (Million US$)
Figure Illumina Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Illumina Recent Development
Table Roche Company Details
Table Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Roche Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Agilent Technologies Recent Development
Table Knome Company Details
Table Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Knome Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Knome Recent Development
Table Genomatix Software Company Details
Table Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Genomatix Software Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Genomatix Software Recent Development
Table GATC Biotech Company Details
Table GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure GATC Biotech Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table GATC Biotech Recent Development
Table Oxford Nanopore Technologies Company Details
Table Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Oxford Nanopore Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Oxford Nanopore Technologies Recent Development
Table Macrogen Company Details
Table Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Macrogen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Macrogen Recent Development
Table Life Technologies Company Details
Table Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Life Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Life Technologies Recent Development
Table DNASTAR Company Details
Table DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure DNASTAR Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table DNASTAR Recent Development
Table Exosome Diagnostics Company Details
Table Biomatters Company Details
Table CLC Bio Company Details
Table BGI Company Details
Table Qiagen Company Details
Table Perkin Elmer Company Details
Table Pacific Bioscience Company Details
Table Partek Company Details
Table GnuBIO Company Details
Table Foundation Medicine Company Details
Table Paradigm Company Details
Table Caris Life Sciences Company Details
Table Myriad Genetics Company Details
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (Million US$) 2019-2025
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions in 2025
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product in 2025
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs